GWN: Nystagmograph
What it covers
A nystagmograph is a device used to measure, record, or visually display the involuntary movements (nystagmus) of the eyeball.
The identification in 21 CFR 882.1460, nystagmograph. FDA gives GWN no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260566 | SMARTVERTIGO Vestibular Assessment System | VertigoDx, Inc. | Jul 30, 2026 | Traditional |
| K243709 | NeuroEars-Anna | Neuroears, Inc. | Aug 25, 2025 | Traditional |
| K242198 | ICS Dizcovery (1091) | Natus Medical Denmark Aps | Feb 14, 2025 | Traditional |
| K242726 | Synapsys VHIT | Inventis S.R.L. | Jan 3, 2025 | Traditional |
| K223047 | NeuroSwift Pro | Neurobit Technologies Co., Ltd. | Jun 29, 2023 | Traditional |
| K203082 | Insight Infrared Video Goggles | Vestibular First | Nov 12, 2020 | Traditional |
| K200534 | VisualEyes | Interacoustics A/S | Aug 12, 2020 | Traditional |
| K192186 | I-Portal Neuro Otologic Test Center, I-Portal Video Nystagmography System, I-Portal Portable Assessment System - Nysragmograph | Neurolign USA, LLC | Nov 29, 2019 | Traditional |
| K181771 | RightEye Vision System | Righteye, LLC | Sep 28, 2018 | Traditional |
| K182214 | DizzyDoctor System 1.0.0 | Dizzydoctor Systems, LLC | Sep 14, 2018 | Traditional |
Clearances by year
23 GWN 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 161 |
| 2025 | 3 | 203 |
| 2023 | 1 | 273 |
| 2020 | 2 | 97 |
| 2019 | 1 | 109 |
| 2018 | 3 | 87 |
| 2017 | 4 | 160 |
| 2016 | 2 | 168 |
| 2015 | 3 | 165 |
| 2013 | 3 | 88 |
Who submits
17 applicants cleared a GWN device since 2011. 48% of the clearances went to applicants in United States, then Denmark (26%), China (9%) and France (4%). By type: Traditional 91% and Special 9%. 2 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Interacoustics A/S | 4 |
| Neuro Kinetics, Inc. | 3 |
| Gn Otometrics | 2 |
| Dizzydoctor Systems, LLC | 1 |
| Inventis S.R.L. | 1 |
| Isen Tech & Trading Company, Ltd. | 1 |
| Isent Tech & Trading Company, Ltd. | 1 |
| Natus Medical Denmark Aps | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 882.1460.
Standards
21 CFR 882.1460 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GWN clearances declared.
Ask about GWN
Questions about GWN
What is FDA product code GWN?
Product code GWN, “Nystagmograph” in FDA's classification database, is a Class II device type under 21 CFR 882.1460 (nystagmograph), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 60 clearances under GWN, 23 of them since 2011.
How many 510(k) clearances are there under GWN?
FDA’s 510(k) database listed 60 clearances under GWN as of Oct 29, 2026, 23 of them decided since 2011; the most recent decision was Jul 30, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a GWN 510(k)?
For the 4 GWN clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 182 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most GWN clearances?
Since 2011: Interacoustics A/S (4), Neuro Kinetics, Inc. (3), Gn Otometrics (2), Dizzydoctor Systems, LLC (1) and Inventis S.R.L. (1). 17 applicants have cleared a GWN device in that time.